Is EPIX or SCHD a better dividend investment in 2026?

EPIX currently yields 840.47% with a 5% 5-year dividend growth rate. SCHD yields 3.44% with 13.05% growth. The better choice depends on your goal: EPIX offers higher current income.

What is the dividend yield difference between EPIX and SCHD?

EPIX has a forward dividend yield of 840.47% ($1.69/share annually). SCHD yields 3.44% ($1.06/share annually). The yield gap is 837.03 percentage points.

Home › Compare › EPIX vs SCHD

EPIX vs SCHD: Dividend Comparison 2026

EPIX yields 840.47% · SCHD yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EPIX wins by $4215412.25M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EPIX

● Live price

840.47%

Share price

$0.20

Annual div

$1.69

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4215412.28M

Annual income

$3,415,908,279,597.25

Full EPIX calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.44%

Share price

$30.68

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$422.61

Full SCHD calculator →

Portfolio growth — EPIX vs SCHD

📍 EPIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EPIX	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EPIX + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EPIX pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPIX

Annual income on $10K today (after 15% tax)

$71,440.13/yr

After 10yr DRIP, annual income (after tax)

$2,903,522,037,657.66/yr

SCHD

Annual income on $10K today (after 15% tax)

$292.49/yr

After 10yr DRIP, annual income (after tax)

$359.22/yr

At 15% tax rate, EPIX beats the other by $2,903,522,037,298.44/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPIX + SCHD for your $10,000?

EPIX: 50%SCHD: 50%

100% SCHD50/50100% EPIX

Portfolio after 10yr

$2107706.16M

Annual income

$1,707,954,140,009.92/yr

Blended yield

81.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPIX right now

EPIX

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$9.50

+4621.7% upside vs current

Range: $2.00 — $17.00

Altman Z

1.1

Piotroski

3/9

SCHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPIX buys

SCHD buys

No recent congressional trades found for EPIX or SCHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEPIXSCHD

Forward yield	840.47% ✓	3.44%
Annual dividend / share	$1.69 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4215412.28M ✓	$29.0K
Annual income after 10y	$3,415,908,279,597.25 ✓	$422.61
Total dividends collected	$4152700.41M ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EPIX vs SCHD ($10,000, DRIP)

Year	EPIX Portfolio	EPIX Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$94,747	$84,047.22	$11,224	$344.10	+$83.5K → EPIX
2	$845,608	$744,228.02	$12,567	$354.98	+$833.0K → EPIX
3	$7,112,413	$6,207,612.95	$14,038	$365.30	+$7.10M → EPIX
4	$56,406,815	$48,796,533.54	$15,648	$375.06	+$56.39M → EPIX
5	$422,031,389	$361,676,096.60	$17,410	$384.27	+$422.01M → EPIX
6	$2,980,575,750	$2,529,002,163.86	$19,335	$392.95	+$2980.56M → EPIX
7	$19,881,694,862	$16,692,478,809.61	$21,437	$401.10	+$19881.67M → EPIX
8	$125,334,964,899	$104,061,551,396.31	$23,733	$408.75	+$125334.94M → EPIX
9	$747,200,001,618	$613,091,589,175.98	$26,237	$415.91	+$747199.98M → EPIX
10	$4,215,412,281,328	$3,415,908,279,597.25	$28,968	$422.61	+$4215412.25M → EPIX

EPIX vs SCHD: Complete Analysis 2026

EPIX — Stock

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Full EPIX Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this EPIX vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPIX vs JEPI EPIX vs O EPIX vs KO EPIX vs MAIN EPIX vs VYM EPIX vs DGRO EPIX vs VIG EPIX vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.